glp-1 news today cardiovascular outcomes 2025 november The Revolution Continues Glucagon-Like Peptide 1 Receptor Agonist

I think the use is going to continue, Dr

or for patients with diabetes and at high risk of liver fibrosis, as there are potential beneficial effects on MASLD.(4) Studies of GLP-1 RA Use in Patients with Cirrhosis A retrospective study in Taiwan, using matched pairs in which half of the patients used GLP-1 RAs, and the other half did not, included patients with type 2 diabetes and compensated cirrhosis

Iron and cancer: more ore to be mined

was higher than that of the control group, and the number of Escherichia and Staphylococcus counts were lower than the control group (36)

Thinking one could substitute for the other in a research context would be a catastrophic error in study design

Many patients report that switching from levothyroxine/Synthroid to Tirosint has significantly reduced their symptoms and has helped with weight loss